QHSLab Inc. (USAQ)

[TommyBoyTrader9460]

Nice slap green..wants to go here..

[Robertscott]

Ready to rebound, POwer hour time USAQ

[TommyBoyTrader9460]

Volume picking up here..looking to go green...

[TommyBoyTrader9460]

Lucky fill there as l2 cleared out..could make a move here..

[budfoxfun]

Their Purchase includes AllergiEnd® Method Patent, Trademark and Website

USAQ

[budfoxfun]

Green heading into power hour!

USAQ

[budfoxfun]

USAQ has entered into a distribution agreement with a prominent physician management services organization (MSO) for its AllergiEnd® allergy diagnostic and allergen immunotherapy products and services. The MSO will facilitate the working relation between USAQ and its physician members, as well as provide marketing and advertising support. Given the size of the MSO’s member roster, the roll out will be done in stages so as to ensure adequate training and staff support.

“Today’s announcement is further evidence of our continued progress and momentum as we expand our independent medical provider practice network. The growing interest in AllergiEnd®’s allergy diagnostic services and allergen immunotherapy products reflects the attractiveness of our value-based tools to proactively address chronic disease, provide preventive care as well as enable the broad market of general practitioner physicians to broaden their practices and revenue base,” said Troy Grogan, CEO of USA Equities Corp.

USAQ

[Let's Roll]

I think you are right about that.

USAQ

[TommyBoyTrader9460]

Just needs a bit more buying pressure..

[budfoxfun]

The company's objectives are to develop proprietary software tools, point of care devices and approaches, providing more granular, timely and specific clinical decision-making information for practicing physicians and other health care providers to address today’s allergy prone, obese, diabetic and cardiovascular disease population.

USAQ

[budfoxfun]

Nice green start here scott!

USAQ

[budfoxfun]

"Litchfield Hills research report highlights the strong sequential improvement in revenue and gross margin we saw in our first quarter financial results. We have made significant progress over the past few months with the commercial launch of AllergiEnd®’s allergy diagnostic and Allergen immunotherapy products expansion of our management team and visibility in the industry among primary care physicians. We continue to expect an increase in revenue and gross margin in the second quarter of 2021” said Troy Grogan, CEO of USA Equities Corp.

USAQ

[Let's Roll]

With new eyes here will go up.

USAQ

[Let's Roll]

Very much so. imho

USAQ

[TommyBoyTrader9460]

Undervalued here..big time..

[Robertscott]

OTCMARKETS company profile, verified 3/2021. https://www.otcmarkets.com/stock/USAQ/profile

[Robertscott]

Chart https://www.stockscores.com/chart.asp?TickerSymbol=USAQ&TimeRange=1300&Interval=d&Volume=1&ChartType=CandleStick&Stockscores=1&ChartWidth=830&ChartHeight=500&LogScale=None&Band=None&avgType1=SMA&movAvg1=&avgType2=SMA&movAvg2=&Indicator1=RSI&Indicator2=AccDist&Indicator3=MACD&Indicator4=None&endDate=&CompareWith=&entryPrice=&stopLossPrice=&candles=redgreen

[budfoxfun]

USA Equities Corp. (USAQ) Acquisition Strengthens USAQ Business Model and Strategic Position

[Let's Roll]

I think we will move up today.

USAQ

[Let's Roll]

Nice volume yesterday.

USAQ

[TommyBoyTrader9460]

$USAQ continues to be under the radar..time to load is now before the public catches on..

[TommyBoyTrader9460]

Let’s clear the ask and close strong..so thin here..

[Let's Roll]

Nice volume today.

USAQ

[TommyBoyTrader9460]

Huge bids up at .53 now,,

[TommyBoyTrader9460]

Someone loading here...nice volume hitting..

[budfoxfun]

.72 up! https://www.otcmarkets.com/stock/USAQ/profile

USAQ

[budfoxfun]

The company announced it has entered into a distribution agreement with a prominent physician management services organization (MSO) for its AllergiEnd® allergy diagnostic and allergen immunotherapy products and services. The MSO will facilitate the working relation between USAQ and its physician members, as well as provide marketing and advertising support. Given the size of the MSO’s member roster, the roll out will be done in stages so as to ensure adequate training and staff support.

“Today’s announcement is further evidence of our continued progress and momentum as we expand our independent medical provider practice network. The growing interest in AllergiEnd®’s allergy diagnostic services and allergen immunotherapy products reflects the attractiveness of our value-based tools to proactively address chronic disease, provide preventive care as well as enable the broad market of general practitioner physicians to broaden their practices and revenue base,” said Troy Grogan, CEO of USA Equities Corp.

USAQ

[budfoxfun]

$USAQ new distribution agreement with a prominent physician management services organization (MSO) for its AllergiEnd® allergy diagnostic and allergen immunotherapy products and services. The MSO will facilitate the working relation between USAQ and its physician members, as well as provide marketing and advertising support. Given the size of the MSO’s member roster, the roll out will be done in stages so as to ensure adequate training and staff support.

[TommyBoyTrader9460]

$USAQ Bidders moving up..spread needs to tighten..

[Let's Roll]

That looks good.

USAQ

[Let's Roll]

That is a good focus for the company.

USAQ

[TommyBoyTrader9460]

News was huge..should be trading higher..

[budfoxfun]

$USAQ’s products are intended to allow general practice physicians to increase revenues by cost effectively diagnosing and treating chronic diseases that are generally referred to specialists. The Company’s products and information service portfolio are directed toward prevention, early detection, management and reversal of allergies, cardio-metabolic and other chronic diseases. Our principal objectives are to develop proprietary software tools, point of care devices and approaches, providing more granular, timely and specific clinical decision-making information for practicing physicians and other health care providers to address today’s allergy prone, obese, diabetic and cardiovascular disease population.

[budfoxfun]

$USAQ big news out: USA Equities Corp Announces the Signing of a Distribution Agreement with a Prominent Physician Management Services Firm For its AllergiEnd® Products and Services https://finance.yahoo.com/news/usa-equities-corp-announces-signing-113000564.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @Yahoo

[budfoxfun]

Their objectives are to develop proprietary software tools, point of care devices and approaches, providing more granular, timely and specific clinical decision-making information for practicing physicians and other health care providers to address today’s allergy prone, obese, diabetic and cardiovascular disease population.

USAQ

[TommyBoyTrader9460]

$USAQ check out the SS!

https://pbs.twimg.com/media/E5IIOQMX0AQ6qX7?format=jpg&name=4096x4096

[budfoxfun]

"Litchfield Hills research report highlights the strong sequential improvement in revenue and gross margin we saw in our first quarter financial results. We have made significant progress over the past few months with the commercial launch of AllergiEnd®’s allergy diagnostic and Allergen immunotherapy products expansion of our management team and visibility in the industry among primary care physicians. We continue to expect an increase in revenue and gross margin in the second quarter of 2021” said Troy Grogan, CEO of USA Equities Corp.

USAQ

[Robertscott]

$USAQ We are a medical device technology company that equips primary care physicians (PCPs) with the digital solutions needed to increase their practice revenues through value-based tools that evaluate and treat chronic disease.

[budfoxfun]

“We continue to strengthen our growing medical device technology and software platform with today’s announced acquisition of the AllergiEnd® intellectual properties. These properties are a great strategic fit that further support our recurring revenue business model focused on non-specialist medical practitioners, which is a large and growing addressable market. We are very well positioned in this market given our deep applications expertise and industry relationships,” said Troy Grogan, CEO of USA Equities Corp.

USAQ

[budfoxfun]

USA Equities Corp. (USAQ) Purchase includes AllergiEnd® Method Patent, Trademark and Website

USAQ

[budfoxfun]

The Acquisition Strengthens USAQ Business Model and Strategic Position

[Let's Roll]

That is good to see.

USAQ

[Let's Roll]

I think more eyes will have seen the news by today.

USAQ

[TommyBoyTrader9460]

$USAQ let’s see If we see more volume today...as yesterday news making the rounds..

[budfoxfun]

Company Profile: https://www.otcmarkets.com/stock/USAQ/profile

USAQ

[budfoxfun]

.74 nhod up heading into power hour!

USAQ

[Let's Roll]

It sure is Screech.

USAQ

[TommyBoyTrader9460]

Bidders getting impatient..as nobody selling into them..could get interesting here

[Screech691]

nice to see that bid moving up to tighten the spread, .74 could fall before close

[TommyBoyTrader9460]

No sellers Here..slap the ask and move this higher